HSKA logo

Heska Corporation Stock Price

NasdaqCM:HSKA Community·US$1.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HSKA Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

HSKA Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet and overvalued.

1 Risk
1 Reward

Heska Corporation Key Details

US$254.9m

Revenue

US$145.5m

Cost of Revenue

US$109.4m

Gross Profit

US$129.4m

Other Expenses

-US$20.0m

Earnings

Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
-1.84
42.93%
-7.86%
22.9%
View Full Analysis

About HSKA

Founded
1988
Employees
808
CEO
Kevin Wilson
WebsiteView website
www.heska.com

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.

Recent HSKA News & Updates

Recent updates

No updates